Functional and morphological liver changes in women taking oral contraceptives. A clinical and ultrastructural study with special reference to the occurrence of cholestasis.
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury; D002758:Cholangiography; D002769:Cholelithiasis / Q000139:chemically induced*; D002779:Cholestasis / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D042882:Gallstones / Q000139:chemically induced; D006801:Humans; D008297:Male; D008656:Mestranol / Q000009:adverse effects; D008854:Microscopy, Electron; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000503:physiopathology; D009640:Norethindrone / Q000009:adverse effects; D011247:Pregnancy
D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D008656:Mestranol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin; D009640:Norethindrone